Tandem Diabetes Care, Inc. (TNDM) Financials
TNDM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.2 billion | 1.0 billion |
| March 31, 2026 | 1.2 billion | 1.0 billion |
| Dec. 31, 2025 | 881.1 million | 725.9 million |
| Sept. 30, 2025 | 874.7 million | 741.7 million |
TNDM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -38.7 million | 15.7 million |
| March 31, 2026 | 4.8 million | 15.7 million |
| Dec. 31, 2025 | 3.1 million | 20.1 million |
| Sept. 30, 2025 | 4.2 million | 21.1 million |
TNDM Net Income
No data available :(
TNDM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 456.0 million | 602.6 million | 136.7 million |
| March 31, 2026 | 570.3 million | 601.8 million | 133.0 million |
| Dec. 31, 2025 | 292.7 million | 425.0 million | 115.0 million |
| Sept. 30, 2025 | 319.1 million | 309.6 million | 118.4 million |
TNDM Shares Outstanding
TNDM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 4.1 million | 46.9 million | 111.6 million | - |
| March 31, 2026 | 6.3 million | 46.0 million | 108.2 million | - |
| Dec. 31, 2025 | 6.7 million | 46.1 million | 113.1 million | - |
| Sept. 30, 2025 | 4.1 million | 47.9 million | 106.5 million | - |
TNDM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 254.6 million | 109.8 million |
| March 31, 2026 | 247.2 million | 110.4 million |
| Dec. 31, 2025 | 290.4 million | 122.9 million |
| Sept. 30, 2025 | 249.3 million | 115.0 million |
TNDM Revenue by Segment
Graph available only for paid members. Upgrade to see it.
TNDM
Price: $22.72
52 week price:
Earnings Per Share: -0.92 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 448000
Ebitda: -11.4 millionMarket Capitalization: 1.6 billion